YTHDF1 promotes the progression of HCC by stimulating the PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition, thereby promoting oncogenicity [45,46]. The gene discussed is MTOR; the disease is hepatocellular carcinoma.